Ads
related to: drugs for insomnia in elderly- Have Questions?
We Have Answers
Visit our FAQ Page
- Want to Learn More?
Get More Info
And Support
- Join Today
For Resources,
Support and More
- Follow Us
On Social Media
For More Info
- Have Questions?
Search results
Results From The WOW.Com Content Network
Somnifacient (from Latin somnus, sleep [1]), also known as sedatives or sleeping pills, is a class of medications that induces sleep. It is mainly used for treatment of insomnia. Examples of somnifacients include benzodiazepines, barbiturates and antihistamines. Around 2-6% of adults with insomnia use somnifacients to aid sleep. [2]
Zolpidem tartrate, a common but potent sedative–hypnotic drug.Used for severe insomnia. Hypnotic (from Greek Hypnos, sleep [1]), or soporific drugs, commonly known as sleeping pills, are a class of (and umbrella term for) psychoactive drugs whose primary function is to induce sleep [2] (or surgical anesthesia [note 1]) and to treat insomnia (sleeplessness).
Chronic use of sedative-hypnotic drugs for the management of insomnia does not have an evidence base and has been discouraged due to concerns including potential adverse drug effects as cognitive impairment (anterograde amnesia), daytime sedation, motor incoordination, and increased risk of motor vehicle accidents and falls. In addition, the ...
Insomnia is observed frequently among older adults and include waking early, taking longer to fall asleep, and frequent waking during the night. ... Medications. Getting older means parts start to ...
This has led to the Z-drugs becoming widely prescribed for the treatment of insomnia particularly in elderly patients. [12] [13] [14] Almost a third of all prescriptions written for Z-drugs are for adults over the age of 65. [15] Long-term use is not recommended as tolerance and addiction can occur. [16]
The review made this determination both because of the relatively large dangers to elderly individuals from zolpidem and other "z-drugs" together with the fact the drugs have "minimal efficacy in treating insomnia." This was a change from the 2012 AGS recommendation, which suggested limiting use to 90 days or less.
Ad
related to: drugs for insomnia in elderly